NYC Eye Surgeon Dr. Gregory Pamel Selected to Serve as Principal Investigator in FDA Clinical Trial on Corneal Collagen Crosslinking
Dr. Gregory Pamel has been selected to be the principal investigator for an FDA clinical trial to evaluate the safety and efficiency of corneal collagen crosslinking (CXL)
View as PDF
April 14, 2011 (FPRC) -- Dr. Gregory Pamel of Pamel Vision & Laser Group, a comprehensive LASIK New York City practice, has been selected as the principal investigator for an FDA clinical trial evaluating the safety and efficiency of corneal collagen crosslinking for keratoconus and ectasia. Dr. Pamel was one of 10 physicians in the United States to be selected to participate in the trial sponsored by Topcon Medical Systems, Inc. In July 2010, Dr. Pamel became the first physician to successfully perform corneal collagen crosslinking using the VEGA UV-A Illumination System.
Keratoconus is a serious disorder that leads to the thinning of the eye’s cornea, eventually resulting in an irregular “cone-like” shape. In individuals who suffer from keratoconus, the light rays focused onto the retina are distorted, thereby causing blurred vision and “irregular” astigmatism, which cannot be corrected with glasses or contact lenses. Although keratoconus is often observed in patients who have a family history of the disease, it can also appear in postoperative vision correction patients, in which case the keratoconus-like condition is referred to as ectasia.
At his state-of-the-art Manhattan LASIK and eye care practice, Dr. Pamel offers a range of effective keratoconus and ectasia treatments, including corneal collagen crosslinking with riboflavin eye drops. Although the current treatment has proven to be effective, as a widely recognized and compassionate eye surgeon, Dr. Pamel is always thrilled to participate in the development and research of new treatments. He is proud to serve as the principal investigator in the latest FDA trials for groundbreaking treatments that will bring new hope to keratoconus and ectasia patients.
For more information on the clinical trials and the latest keratoconus and ectasia treatment options, please contact Pamel Vision and Laser Group at (888) 657-2010 or (212) 355-2215.
Dr. Gregory Pamel in the Media
Dr. Gregory Pamel is a nationally recognized eye surgeon who has previously served in several FDA clinical trials. His expertise is frequently sought by major media outlets, including the Discovery Channel, New York News 1, ABC, CBS, FOX, UPN and CNN, just to name a few. Dr. Pamel was recently selected by his peers for inclusion in the "Super Doctors" issue of the New York Times Magazine. He is a recipient of the prestigious American Academy of Ophthalmology Achievement Award for his participation in educational forums, where he taught other eye surgeons how to employ the latest techniques and technologies in eye surgery. Most importantly, Dr. Pamel is a skilled ophthalmologist who has helped countless New York City cataract surgery, LASIK and keratoconus Manhattan patients achieve better vision.
To learn more, please contact Dr. Pamel and his staff at (888) 657-2010 or (212) 355-2215.
Send an email to Dr. Gregory Pamel of Dr. Gregory Pamel
Recent Press Releases By The Same User
New Jersey Surgeon Dr. Robert Zubowski Featured in World Progress Report (Wed 4th May 11)
Philadelphia Cataract Surgeon Dr. James Lewis Launches a New Website (Wed 27th Apr 11)
Phoenix Eye Surgeon Tariq Qamar, MD, Listed 'Top Doctor' in Phoenix Magazine (Sat 16th Apr 11)
NYC Eye Surgeon Dr. Sandra Belmont Appears in a National News Story on LASIK Surgery (Sat 16th Apr 11)
New York City Plastic Surgeon Dr. Joshua Greenwald Opens New Facility (Thu 14th Apr 11)